Early trial findings demonstrate the efficacy of FGFR inhibitors and PARP/ATR inhibitor combos in a variety of tumor types.

Published Date: 19 Apr 2023

At the American Association for Cancer Research (AACR) Annual Meeting 2023, researchers from The University of Texas MD Anderson Cancer Center presented promising results from a number of clinical trials.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Does pollution cause cancer?

2.

AI is equally capable of reading breast cancer scans as human radiologists.

3.

EVP Beats Cisplatin for Resectable MIBC

4.

New research points out a promising strategy for treating metastatic medulloblastoma

5.

Academics + Pharma = Big Bucks; New CAR-T Warnings; Patients Seek Cancer Tests.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot